LUNG CANCER, NONSMALL CELL
Clinical trials for LUNG CANCER, NONSMALL CELL explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER, NONSMALL CELL trials appear
Sign up with your email to follow new studies for LUNG CANCER, NONSMALL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug cocktail shows promise against tough lung cancer
Disease control OngoingThis study tests a combination of three drugs—nivolumab, ipilimumab, and nintedanib—in people with advanced non-small cell lung cancer that cannot be cured. The goal is to see if the combination can shrink tumors and control the disease. Participants must be 18 or older and have …
Matched conditions: LUNG CANCER, NONSMALL CELL
Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Can blood tests predict lung cancer return after immunotherapy?
Knowledge-focused OngoingThis study looks at 23 people with advanced non-small cell lung cancer who finished at least 20 months of immunotherapy. Researchers want to see if certain immune markers and DNA in the blood can predict if the cancer will come back. The goal is to better understand who might nee…
Matched conditions: LUNG CANCER, NONSMALL CELL
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 17, 2026 03:09 UTC
-
New study tracks risks of combining lung cancer treatments
Knowledge-focused OngoingThis study looks at 12 people with stage IV non-small cell lung cancer who are already receiving immunotherapy (nivolumab or pembrolizumab) and also get palliative radiation to the chest. The goal is to track side effects from the combination and how it affects patients' quality …
Matched conditions: LUNG CANCER, NONSMALL CELL
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC